FTIR investigation of the secondary structure of type I collagen: New insight into the amide III band.


Journal

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
ISSN: 1873-3557
Titre abrégé: Spectrochim Acta A Mol Biomol Spectrosc
Pays: England
ID NLM: 9602533

Informations de publication

Date de publication:
15 Mar 2020
Historique:
received: 02 07 2019
revised: 02 12 2019
accepted: 27 12 2019
pubmed: 14 1 2020
medline: 28 10 2020
entrez: 14 1 2020
Statut: ppublish

Résumé

This work presents a thorough study on the Amide III band in fibrous proteins using Fourier Transformed Infrared Spectroscopy (FTIR). Type I collagen was chosen as a model for this family of proteins, not only because of its important role in mammalian tissues, but also for its involvement in several pathologies. In order to disclose the conformational information contained in the collagen bands, the spectral characteristics of Amide III of type I collagen were related to the ones of Amide I band, performing experiments of thermal denaturation of the protein in acidic solution. Data acquired allowed to observe the protein unfolding and retrieve information about its structural arrangements during the thermal cycle. Taking as guideline the well-known behaviour of the Amide I band, we correlated the structural changes deducible from Amide I analysis with the ones detectable for Amide III band, by exploiting three spectral analysis techniques, namely 2D-correlation analysis, second derivative analysis, and peak-fitting. This approach enabled us to jointly support the obtained results and finally to assign the components of the Amide III of a typical fibrous protein, such as type I collagen, to its characteristic secondary structure.

Identifiants

pubmed: 31927236
pii: S1386-1425(19)31405-2
doi: 10.1016/j.saa.2019.118006
pii:
doi:

Substances chimiques

Amides 0
Collagen Type I 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118006

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Chiaramaria Stani (C)

Elettra - Sincrotrone Trieste, Strada Statale 14 - km 163,5 in AREA Science Park, 34149 Basovizza, Trieste, Italy.

Lisa Vaccari (L)

Elettra - Sincrotrone Trieste, Strada Statale 14 - km 163,5 in AREA Science Park, 34149 Basovizza, Trieste, Italy.

Elisa Mitri (E)

Elettra - Sincrotrone Trieste, Strada Statale 14 - km 163,5 in AREA Science Park, 34149 Basovizza, Trieste, Italy.

Giovanni Birarda (G)

Elettra - Sincrotrone Trieste, Strada Statale 14 - km 163,5 in AREA Science Park, 34149 Basovizza, Trieste, Italy. Electronic address: giovanni.birarda@elettra.eu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH